| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Insulin resistanceRIP140FSP27MAP4k4AdiponectinBurns (Traumatology)LipotoxicitySteatohepatosisHepatitis CObesityDiuretic agents (BASKET)MacrophagesTyrosine phosphatasePolycystic ovary syndromeMetabolic syndromeResistinEndothelial dysfunctionPI3KFatty acids (Free)IGF1Receptor (Insulin)Donohue s syndromeRabson Mendenhall s syndromeMitochondria (BASKET)Insulin (BASKET)eNOSMetforminRBP4LipocalinLipocalin2Adipose tissue (BASKET)D chiro inositol glycans| 1 | 1999 | Insulin resistance syndrome: options for treatment. | 
| + | - | nl | South Med J 92(1):2-15 (1999) |
| 2 | 1997 | The deadly quartet--the insulin resistance syndrome. | 
| + | - | nl | South Med J 90(12):1162-8 (1997) |
| 3 | 1997 | Molecular mechanisms of inherited insulin resistance. | 
| + | - | nl | QJM 90(9):557-62 (1997) |
| 4 | 2009 | Saturated fatty acids and insulin resistance. | 
| + | - | nl | J Med Invest 56(3-4):88-92 (2009) |
| 5 | 1989 | Molecular genetics of severe insulin resistance. | 
| + | - | nl | Yale J Biol Med 62(5):533-47 (1989) |
| 6 | 2008 | Insulin resistance: a potential new target for therapy in patients with heart failure. | 
| + | - | nl | Cardiovasc Ther 26(3):203-13 (2008) |
| 7 | 2006 | Insulin resistance as a membrane microdomain disorder. | 
| + | - | nl | Biol Pharm Bull 29(8):1532-7 (2006) |
| 8 | 2001 | An overview of pathophysiology and treatment of insulin resistance. | 
| + | - | nl | Indian J Physiol Pharmacol 45(1):22-36 (2001) |
| 9 | 2008 | Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability. | 
| + | - | nl | Mediators Inflamm 2008(-):767623 (2008) |
| 10 | 1995 | Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. | 
| + | - | nl | Am J Clin Nutr 61(4 Suppl):980S-986S (1995) |
| 11 | 2001 | Insulin resistance in polycystic ovary syndrome: progress and paradoxes. | 
| + | - | nl | Recent Prog Horm Res 56(-):295-308 (2001) |
| 12 | 2001 | Insulin resistance and its treatment by thiazolidinediones. | 
| + | - | nl | Recent Prog Horm Res 56(-):265-94 (2001) |
| 13 | 2007 | Molecular mechanism of insulin resistance. | 
| + | - | nl | J Biosci 32(2):405-13 (2007) |
| 14 | 2006 | Spectrum of renal diseases associated with extreme forms of insulin resistance. | 
| + | - | nl | Clin J Am Soc Nephrol 1(4):616-22 (2006) |
| 15 | 2008 | Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. | 
| + | - | nl | Am J Physiol Endocrinol Metab 295(1):E17-28 (2008) |
| 16 | 2008 | Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. | 
| + | - | nl | Am J Physiol Endocrinol Metab 294(1):E15-26 (2008) |
| 17 | 2007 | Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. | 
| + | - | nl | Am J Physiol Endocrinol Metab 292(3):E654-67 (2007) |
| 18 | 2002 | Mouse models of insulin resistance. | 
| + | - | nl | Am J Physiol Endocrinol Metab 282(5):E977-81 (2002) |
| 19 | 2008 | Role of mitochondrial dysfunction in insulin resistance. | 
| + | - | nl | Circ Res 102(4):401-14 (2008) |
| 20 | 2002 | Why test the children?: Understanding insulin resistance, its complications, and its progression. | 
| + | - | nl | Diabetes Care 25(12):2350-1 (2002) Jones KL |
| 21 | 2008 | How to measure hepatic insulin resistance? | 
| + | - | nl | Diabetes Metab 34(6 Pt 2):664-73 (2008) |
| 22 | 2008 | Mitochondrial energetics and insulin resistance. | 
| + | - | nl | Endocrinology 149(3):950-4 (2008) |
| 23 | 2005 | Insulin resistance and steatosis in hepatitis C virus infection. | 
| + | - | nl | Gut 54(7):903-6 (2005) |
| 24 | 2000 | Insulin sensitivity and its measurement: structural commonalities among the methods. | 
| + | - | nl | J Clin Endocrinol Metab 85(12):4426-33 (2000) |
| 25 | 1998 | Clinical review 97: Syndromes of severe insulin resistance. | 
| + | - | nl | J Clin Endocrinol Metab 83(9):3025-30 (1998) |
| 26 | 2008 | Insulin sensitivity: modulation by nutrients and inflammation. | 
| + | - | nl | J Clin Invest 118(9):2992-3002 (2008) |
| 27 | 2009 | Molecular mechanisms of insulin resistance in chronic hepatitis C. | 
| + | - | nl | World J Gastroenterol 15(35):4356-64 (2009) |
| 28 | 2005 | Insulin resistance: a metabolic pathway to chronic liver disease. | 
| + | - | nl | Hepatology 42(5):987-1000 (2005) |
| 29 | 2008 | RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27. | 
| + | - | nl | Acta Physiol (Oxf) 192(1):103-15 (2008) |
| 30 | 2006 | Etiology of insulin resistance. | 
| + | - | nl | Am J Med 119(5 Suppl 1):S10-6 (2006) |
| 31 | 2010 | Adiponectin in insulin resistance: lessons from translational research. | 
| + | - | nl | Am J Clin Nutr 91(1):258S-261S (2010) Ziemke F |
| 32 | 2008 | Postburn trauma insulin resistance and fat metabolism. | 
| + | - | nl | Am J Physiol Endocrinol Metab 294(1):E1-9 (2008) |
| 33 | 2007 | Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. | 
| + | - | nl | Am J Physiol Heart Circ Physiol 293(4):H2009-23 (2007) |
| 34 | 2010 | Acyl-CoA synthesis, lipid metabolism and lipotoxicity. | 
| + | - | nl | Biochim Biophys Acta 1801(3):246-51 (2010) |
| 35 | 2010 | Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. | 
| + | - | nl | Biochim Biophys Acta 1801(3):252-65 (2010) |
| 36 | 2007 | Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. | 
| + | - | nl | Cell Cycle 6(8):888-94 (2007) |
| 37 | 2011 | Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis. | 
| + | - | nl | World J Gastroenterol 17(36):4055-62 (2011) |
| 38 | 2010 | Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. | 
| + | - | nl | World J Gastroenterol 16(16):1943-52 (2010) |
| 39 | 2004 | Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. | 
| + | - | nl | Physiology (Bethesda) 19(-):183-90 (2004) |
| 40 | 2007 | Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. | 
| + | - | nl | Physiology (Bethesda) 22(-):252-60 (2007) |
| 41 | 2008 | Mechanistic insights into diuretic-induced insulin resistance. | 
| + | - | nl | Hypertension 52(6):1009-11 (2008) |
| 42 | 2010 | Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity. | 
| + | - | nl | Hypertension 55(1):15-7 (2010) |
| 43 | 2005 | Mechanisms of insulin resistance in humans and possible links with inflammation. | 
| + | - | nl | Hypertension 45(5):828-33 (2005) |
| 44 | 2010 | The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. | 
| + | - | nl | Circ Res 106(1):58-67 (2010) |
| 45 | 2007 | Innate immune pathway links obesity to insulin resistance. | 
| + | - | nl | Circ Res 100(11):1531-3 (2007) Shah PK |
| 46 | 2007 | The macrophage at the crossroads of insulin resistance and atherosclerosis. | 
| + | - | nl | Circ Res 100(11):1546-55 (2007) |
| 47 | 2010 | Pathogenesis of insulin resistance in skeletal muscle. | 
| + | - | nl | J Biomed Biotechnol 2010(-):476279 (2010) |
| 48 | 2010 | Skeletal muscle insulin resistance in endocrine disease. | 
| + | - | nl | J Biomed Biotechnol 2010(-):527850 (2010) |
| 49 | 2009 | Hepatic triacylglycerol accumulation and insulin resistance. | 
| + | - | nl | J Lipid Res 50 Suppl(-):S74-9 (2009) |
| 50 | 2002 | Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance. | 
| + | - | nl | J Clin Endocrinol Metab 87(6):2474-80 (2002) |
| 51 | 2010 | Limitations in surrogate measures of insulin resistance. | 
| + | - | nl | J Clin Endocrinol Metab 95(11):4874-6 (2010) Buchanan TA |
| 52 | 2004 | Insulin resistance syndrome in children. | 
| + | - | nl | J Clin Endocrinol Metab 89(6):2526-39 (2004) |
| 53 | 2010 | Hypoadiponectinemia--cause or consequence of human "insulin resistance"? | 
| + | - | nl | J Clin Endocrinol Metab 95(4):1544-54 (2010) |
| 54 | 2007 | Does insulin resistance need resistin? | 
| + | - | nl | J Clin Endocrinol Metab 92(6):2036-7 (2007) Wentworth JM |
| 55 | 2008 | An integrated view of insulin resistance and endothelial dysfunction. | 
| + | - | nl | Endocrinol Metab Clin North Am 37(3):685-711, ix-x (2008) |
| 56 | 2008 | Obesity and free fatty acids. | 
| + | - | nl | Endocrinol Metab Clin North Am 37(3):635-46, viii-ix (2008) |
| 57 | 2007 | IGF-I treatment of insulin resistance. | 
| + | - | nl | Eur J Endocrinol 157 Suppl 1(-):S51-6 (2007) |
| 58 | 2010 | The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. | 
| + | - | nl | Endocr Rev 31(1):25-51 (2010) |
| 59 | 2007 | Cardiovascular actions of insulin. | 
| + | - | nl | Endocr Rev 28(5):463-91 (2007) |
| 60 | 2009 | Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. | 
| + | - | nl | Endocr Rev 30(1):1-50 (2009) |
| 61 | 2004 | Mouse models of insulin resistance. | 
| + | - | nl | Physiol Rev 84(2):623-47 (2004) |
| 62 | 2007 | Disordered lipid metabolism and the pathogenesis of insulin resistance. | 
| + | - | nl | Physiol Rev 87(2):507-20 (2007) |
| 63 | 2008 | Inflammation and insulin resistance. | 
| + | - | nl | FEBS Lett 582(1):97-105 (2008) |
| 64 | 2007 | Lipocalins and insulin resistance: etiological role of retinol-binding protein 4 and lipocalin-2? | 
| + | - | nl | Clin Chem 53(1):5-7 (2007) van Dam RM |
| 65 | 2004 | Tissue-specific insulin resistance. | 
| + | - | nl | Postgrad Med J 80(946):435 (2004) |
| 66 | 2009 | Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance. | 
| + | - | nl | Swiss Med Wkly 139(47-48):678-84 (2009) |
| 67 | 2007 | Antioxidants: do they have a role in the treatment of insulin resistance? | 
| + | - | nl | Indian J Med Res 125(3):355-72 (2007) |
| 68 | 2010 | Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. | 
| + | - | nl | Mol Cell Endocrinol 318(1-2):44-53 (2010) |
| 69 | 2008 | Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. | 
| + | - | nl | Anesthesiology 109(1):137-48 (2008) |
| 70 | 2010 | Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages. | 
| + | - | nl | Mediators Inflamm 2010(-):219583 (2010) |
| 71 | 2007 | Mechanisms of obesity-associated insulin resistance: many choices on the menu. | 
| + | - | nl | Genes Dev 21(12):1443-55 (2007) |
| 72 | 2008 | Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. | 
| + | - | nl | Nat Rev Mol Cell Biol 9(5):367-77 (2008) |
| 73 | 2010 | D-chiro-inositol glycans in insulin signaling and insulin resistance. | 
| + | - | nl | Mol Med 16(11-12):543-52 (2010) |
| 74 | 2008 | Inflammatory mechanisms in the regulation of insulin resistance. | 
| + | - | nl | Mol Med 14(3-4):222-31 (2008) |